May 11, 2023 (Earnings Report)Dear Reader,We just identified several stocks that are expected to release earnings very soon.If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments.Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.
Airsculpt Technologies, Inc.
Symbol: AIRS
Recent Price: $5.04
Average Analyst Price Target: $6.38 (26.59%)
Market Cap: $296.02M
Last Year's EPS: -$0.01
Consensus EPS Forecast: $0.13
Expected Earnings Date: May 11 2023
Recent Analyst Action: Whit Mayo, analyst at SVB Securities, reiterates coverage on Airsculpt Technologies, Inc. (AIRS) in the Healthcare sector with a Buy rating and a price target of $ 6.5 (1 month ago).
TipRanks.com also reports that Airsculpt Technologies, Inc. currently has 4 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $6.38 . The target pricing ranges from a high forecast of $8.00 down to a low forecast of $5.00. Airsculpt Technologies, Inc. (AIRS)’s last closing price was $5.04 which would put the average price target at 26.59% upside.Here are 3rd party ratings for AIRS:
- TipRanks.com: Moderate Buy
- TradingView.com: n/a (possibly response change)
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Hold, Top 48% (121 out of 250)
--------------------------------------------------------------------------
Vitesco Technologies Group AG
Symbol: VTSCF
Recent Price: $59.28
Average Analyst Price Target: $83.35 (39.84%)
Market Cap: $2.72B
Last Year's EPS: $0.14
Consensus EPS Forecast: $0.78
Expected Earnings Date: May 11 2023
Recent Analyst Action: Alexandre Raverdy, analyst at Kepler Capital , reiterates coverage on Vitesco Technologies Group AG (VTSCF) in the Industrial Goods sector with a Hold rating and a price target of $ 62.54 (6 days ago).
TipRanks.com also reports that Vitesco Technologies Group AG currently has 9 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $83.35 . The target pricing ranges from a high forecast of $115.83 down to a low forecast of $62.88. Vitesco Technologies Group AG (VTSCF)’s last closing price was $59.28 which would put the average price target at 39.84% upside.Here are 3rd party ratings for VTSCF:
- TipRanks.com: Strong Buy
- TradingView.com: n/a (possibly response change)
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: n/a
- Zacks.com: n/a, n/a
--------------------------------------------------------------------------
Terran Orbital Corp
Symbol: LLAP
Recent Price: $1.88
Average Analyst Price Target: $10.67 (467.55%)
Market Cap: $268.28M
Last Year's EPS: -$0.85
Consensus EPS Forecast: -$0.16
Expected Earnings Date: May 11 2023
Recent Analyst Action: Ronald Epstein, analyst at Bank of America Securities, reiterates coverage on Terran Orbital Corp (LLAP) in the Technology sector with a Buy rating and a price target of $ 7 (1 month ago).
TipRanks.com also reports that Terran Orbital Corp currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $10.67 . The target pricing ranges from a high forecast of $15.00 down to a low forecast of $7.00. Terran Orbital Corp (LLAP)’s last closing price was $1.88 which would put the average price target at 467.55% upside.Here are 3rd party ratings for LLAP:
- TipRanks.com: Strong Buy
- TradingView.com: n/a (possibly response change)
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Sell, Bottom 28% (179 out of 250)
--------------------------------------------------------------------------
Tempest Therapeutics
Symbol: TPST
Recent Price: $2.06
Average Analyst Price Target: $20.50 (895.15%)
Market Cap: $21.65M
Last Year's EPS: -$1.18
Consensus EPS Forecast: -$0.64
Expected Earnings Date: May 11 2023
Recent Analyst Action: Joseph Pantginis, analyst at H.C. Wainwright, reiterates coverage on Tempest Therapeutics (TPST) in the Healthcare sector with a Buy rating and a price target of $ 35 (1 week ago).
TipRanks.com also reports that Tempest Therapeutics currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $20.50 . The target pricing ranges from a high forecast of $35.00 down to a low forecast of $6.00. Tempest Therapeutics (TPST)’s last closing price was $2.06 which would put the average price target at 895.15% upside.Here are 3rd party ratings for TPST:
- TipRanks.com: Moderate Buy
- TradingView.com: n/a (possibly response change)
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Hold, Top 45% (113 out of 250)
--------------------------------------------------------------------------
Palisade Bio
Symbol: PALI
Recent Price: $1.59
Average Analyst Price Target: $5.00 (214.47%)
Market Cap: $9.31M
Last Year's EPS: -$13
Consensus EPS Forecast: -$0.72
Expected Earnings Date: May 11 2023
Recent Analyst Action: Naz Rahman, analyst at Maxim Group, reiterates coverage on Palisade Bio (PALI) in the Healthcare sector with a Buy rating and a price target of $ 5 (1 month ago).
TipRanks.com also reports that Palisade Bio currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $5.00 . The target pricing ranges from a high forecast of $5.00 down to a low forecast of $5.00. Palisade Bio (PALI)’s last closing price was $1.59 which would put the average price target at 214.47% upside.Here are 3rd party ratings for PALI:
- TipRanks.com: Moderate Buy
- TradingView.com: n/a (possibly response change)
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Buy, Top 40% (99 out of 250)
--------------------------------------------------------------------------
Invivyd
Symbol: IVVD
Recent Price: $1.42
Average Analyst Price Target: $3.00 (111.27%)
Market Cap: $129.94M
Last Year's EPS: -$0.93
Consensus EPS Forecast: -$0.35
Expected Earnings Date: May 11 2023
Recent Analyst Action: Patrick Trucchio, analyst at H.C. Wainwright, reiterates coverage on Invivyd (IVVD) in the Healthcare sector with a Buy rating and a price target of $ 5 (1 day ago).
TipRanks.com also reports that Invivyd currently has 2 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $3.00 . The target pricing ranges from a high forecast of $5.00 down to a low forecast of $1.00. Invivyd (IVVD)’s last closing price was $1.42 which would put the average price target at 111.27% upside.Here are 3rd party ratings for IVVD:
- TipRanks.com: Hold
- TradingView.com: n/a (possibly response change)
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Hold, Top 40% (99 out of 250)
--------------------------------------------------------------------------
Evotec AG
Symbol: EVO
Recent Price: $10.34
Average Analyst Price Target: $12.00 (16.05%)
Market Cap: $3.20B
Last Year's EPS: -$0.22
Consensus EPS Forecast: $0.13
Expected Earnings Date: May 09 2023
Recent Analyst Action: James Quigley, analyst at Morgan Stanley, reiterates coverage on Evotec AG (EVO) in the Healthcare sector with a Hold rating and a price target of $ 12 (1 month ago).
TipRanks.com also reports that Evotec AG currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $12.00 . The target pricing ranges from a high forecast of $12.00 down to a low forecast of $12.00. Evotec AG (EVO)’s last closing price was $10.34 which would put the average price target at 16.05% upside.Here are 3rd party ratings for EVO:
- TipRanks.com: Moderate Buy
- TradingView.com: n/a (possibly response change)
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Weak buy
- Zacks.com: Hold, Top 45% (113 out of 250)
--------------------------------------------------------------------------
To Your Financial Future,
The Editor, WallStreetSectors.com
